Empty Capsules Market - Rapid Advancements Related To Development And Growth in Popularity over Other Drug Delivery Forms Are Expected To Drive the Market Growth In The Near Future

The Empty Capsules Market is expected to grow at an average CAGR of 9.1% between 2018 and 2025 by 2025 and is expected to reach $ 375.5 million by 2025. The raw pork sector accounted for one-third of the overall market in 2017.

Capsules are the second most common form of administration for oral administration of the drug after purification. These are mainly used in functional food and pharmaceutical fields. Reducing drug development timelines under standard conditions has been a key factor in the production of drugs delivered in capsule form between pharmaceutical and health food manufacturers. In addition, this strategy allows pharmaceutical manufacturers to shorten the time required to introduce drugs into the market. Other benefits include protecting the drug substance from a variety of external factors such as natural light or artificial light during production, storage, management and use. In addition, capsules act as effective shields to prevent degradation of closed drugs.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/985

The major companies profiled in this report include ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd, and Sunil Healthcare Ltd. The other prominent players in the value chain include Patheon Ltd., Nectar Lifesciences Ltd., JC Biological Technologies, Natural Capsules Ltd., Zhejiang Huili Capsules Co., Ltd., Healthcaps India Limited, HTC Group Limited, and Nanjing Saturn Pharmaceutical Technology Co., Ltd.

Depending on the product, the global empty capsule market is classified as gelatin capsules and non-gelatin capsules. The gelatin capsules are further divided into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs). The gelatin segment dominated the global market in 2017 and is expected to maintain this trend throughout the forecast period. Gelatin was the standard choice of raw materials for the development of hard shell capsules that can efficiently contain active pharmaceutical ingredients (API). Non-gelatin capsule segments, on the other hand, are expected to grow at the fastest pace from 2018 to 2025. The growing demand for hydropropylmethylcellulose (HPMC) capsules is a major contributor to the strong CAGR of the non-gelatin capsule segment worldwide. In addition, major changes in consumer behavior have been observed with the use of vegetarian capsules in recent years.

Depending on the therapeutic use, the market is divided into antibiotics and antimicrobials, vitamins and dietary supplements, antacids and anti-obesity agents, cardiac therapies and other applications. The antibiotics and antimicrobial sectors have dominated the global market in 2017 and are expected to maintain this position throughout the forecast period. However, the Vitamin & Dietary Supplement segment is expected to grow at the fastest pace throughout the forecast period. In recent years, consumption of antibiotics has increased significantly. Increased consumption of prescription or prescription-free antibiotics has led to an increase in the use of antibiotics worldwide.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/985

The Asia Pacific region is expected to have the highest growth rates throughout the forecast period due to its high population base, increased disposable income, improved patient awareness of chronic diseases, and a healthy lifestyle. Countries like India and China are also contributing greatly to the growth of the Asia Pacific Empty Capsule market due to the constantly evolving pharmaceutical industry in these countries.

Key Findings of the Empty Capsules Market:
• The CIS (Commonwealth of Independent States) region accounted for one-ninth share of the global market in 2017.
• The market for cardiac therapy drugs utilizing empty capsules are expected to grow at the second-highest CAGR of 10.4% from 2018 to 2025.
• North America dominated the global empty capsules market, accounting for the maximum share in 2017 and is expected to retain a similar trend during the forecast period.
• Hydroxypropyl methylcellulose (HPMC) capsules raw material is growing at the fastest pace during the forecast period.
• The SGCs segment is estimated to grow at the highest CAGR of 8.1% from 2018 to 2025.

Access Full Summery @ https://www.alliedmarketresearch.com/empty-capsules-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.